The average one-year price target for Roivant Sciences (NasdaqGS:ROIV) has been revised to $32.44 / share. This is an ...

WASHINGTON, DC – When billionaires are in the spotlight for their oversized influence in Washington, especially in the Trump administration, comes this news: Vivek Ramaswamy’s wealth has soared even ...

In November 2025, Abbott struck an agreement to acquire Exact Sciences for approximately $21 billion. Madison, Wisconsin–based Exact Sciences develops cancer screening and diagnostic tests. Its ...

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 10:00 AM ESTCompany ParticipantsPavel Raifeld - ...

Radiant becomes one of the world's first infrastructure companies engineered from the ground up to deliver integrated AI compute. Radiant's access to scaled capital from Brookfield, alongside data ...

Biotech heavyweight Gilead Sciences is set to acquire a Rockville-area cancer therapy developer in a deal valued at nearly $8 billion.